100+ Free SAIIPL SA Patent Law & Practice Practice Questions

Pass your SAIIPL Trade Mark Practitioners' Examination — SA Patent Law and Practice exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More SAIIPL Trade Mark Practitioners Qualification

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

SAIIPL Trade Mark Practitioners' Examination — SA Copyright Law and Practice (South Africa)

Practice Questions100 questions

SAIIPL Trade Mark Practitioners' Examination — SA Design Law and Practice (South Africa)

Practice Questions100 questions

SAIIPL Trade Mark Practitioners' Examination — SA Trade Mark Law and Practice (South Africa)

Practice Questions100 questions

SAIIPL Trade Mark Practitioners' Examination — Trade Mark Law and Formalities (South Africa)

Practice Questions100 questions

SAIIPL Trade Mark Practitioners' Examination — Trade Mark Litigation (South Africa)

Practice Questions100 questions

Sample SAIIPL SA Patent Law & Practice Practice Questions

Try these sample questions to test your SAIIPL SA Patent Law & Practice exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Under Section 25(1) of the South African Patents Act 57 of 1978, which three cumulative statutory requirements must a patentable invention satisfy?

A.It must be novel, involve an inventive step, and be capable of being used or applied in trade, industry or agriculture

B.It must be aesthetically pleasing, novel, and registered with the Trade Marks Office

C.It must be useful, commercially profitable, and filed by a South African citizen

D.It must be secret, non-obvious, and accompanied by a functional design registration

Explanation: Section 25(1) of the Patents Act 57 of 1978 provides that a patent may be granted for any new invention which involves an inventive step and which is capable of being used or applied in trade, industry or agriculture. Aesthetic qualities, citizenship, commercial profitability, and secret use are not statutory criteria under Section 25(1).

2How does Section 25(2)(f) of the Patents Act 57 of 1978 treat a program for a computer regarding patentability?

A.Computer programs are absolutely barred from patent protection under all circumstances

B.Computer programs are excluded from patentability only to the extent that a patent application relates to a computer program 'as such'

C.Computer programs are automatically patentable without needing to demonstrate an inventive step

D.Computer programs are patentable only if filed as functional designs under the Designs Act

Explanation: Section 25(2)(f) read with Section 25(3) specifies that a computer program is excluded from patentability only to the extent to which a patent or application for a patent relates to that item 'as such'. If a computer-implemented invention produces a technical outcome or solves a technical problem beyond a bare computer program, it may be patentable.

3Which of the following items is explicitly listed in Section 25(2) of the Patents Act 57 of 1978 as a non-patentable subject matter 'as such'?

A.A scheme, rule or method for performing a mental act, playing a game or doing business

B.A synthetic chemical compound synthesized for pharmaceutical use

C.A mechanical valve mechanism for industrial water filtration

D.A genetically modified microorganism used in industrial fermentation

Explanation: Section 25(2)(e) explicitly lists a scheme, rule or method for performing a mental act, playing a game or doing business among non-patentable subject matter. Chemical compounds, mechanical valves, and microbiological products are patentable subject matter provided they meet the criteria of Section 25(1).

4Under Section 25(8) of the Patents Act 57 of 1978, why are methods of treatment of the human body by surgery or therapy deemed non-patentable?

A.They are deemed not to be capable of being used or applied in trade, industry or agriculture

B.They are deemed to lack novelty by statutory presumption

C.They belong exclusively to the State under Section 78

D.They are classified as artistic creations under Section 25(2)(d)

Explanation: Section 25(8) provides that an invention of a method of treatment of the human or animal body by surgery or therapy or of diagnosis practiced on the human or animal body shall be deemed not to be capable of being used or applied in trade, industry or agriculture. This statutory deeming provision renders medical treatment methods non-patentable under Section 25(1).

5A pharmaceutical company invents a known chemical compound 'X' that was previously used as a dye, but discovers it effectively treats malaria. Can compound 'X' be patented in South Africa for medical use?

A.Yes, Section 25(9) permits patenting a known substance for use in a method of medical treatment if its use in such a method does not form part of the state of the art

B.No, because known chemical compounds can never be patented under any circumstances once published

C.Yes, but only if the applicant also registers a trade mark for the chemical formula

D.No, because Section 25(8) bans all patents relating to pharmaceuticals

Explanation: Section 25(9) explicitly provides that the exclusion of medical methods under Section 25(8) shall not prevent a patent from being granted for a substance or composition for use in a method of medical treatment, provided its use in such a method does not form part of the state of the art. This allows first and subsequent medical use claims for substances.

6Which standard of novelty applies to patent applications in South Africa under Section 25(5) and 25(6) of the Patents Act 57 of 1978?

A.Absolute (worldwide) novelty

B.Relative (local South African) novelty only

C.Commonwealth novelty only

D.Commercial novelty based on sales in South Africa

Explanation: South Africa enforces an absolute (worldwide) novelty standard under Section 25(5) and Section 25(6). The state of the art comprises all matter made available to the public anywhere in the world (in South Africa or elsewhere) by written or oral description, use, or in any other way before the priority date.

7Under Section 25(6) of the Patents Act 57 of 1978, what constitutes the 'state of the art' for testing novelty?

A.All matter made available to the public in South Africa or elsewhere by written or oral description, use or in any other way before the priority date

B.Only registered South African patents published within the last 10 years

C.Only written textbooks published in English within South Africa

D.Pending patent applications filed at CIPC that have not yet been accepted

Explanation: Section 25(6) defines the state of the art as comprising all matter (whether a product, a process, information about either, or anything else) which has been made available to the public (in the Republic or elsewhere) by written or oral description, by use or in any other way before the priority date of the invention.

8Under Section 26(a) of the Patents Act 57 of 1978, what is the effect of an inventor's secret prior commercial use of an invention in South Africa for profit before the priority date?

A.It forms part of the state of the art and destroys the novelty of a subsequent patent application

B.It grants the inventor an automatic 5-year priority extension

C.It has no legal effect as long as the use was secret

D.It converts the patent application automatically into a trade mark application

Explanation: Section 26(a) provides that an invention shall be deemed to form part of the state of the art if it has been used secretly and on a commercial scale, or secretly for commercial profit, in the Republic from a date prior to the priority date. Secret commercial exploitation thus destroys novelty.

9According to Section 25(4)(a) of the Patents Act 57 of 1978, a patent shall NOT be granted for an invention if:

A.Its publication or exploitation would be expected to encourage offensive or immoral behaviour

B.It requires more than R100,000 to manufacture commercially

C.It competes directly with an existing South African state-owned enterprise

D.It has not been tested in a clinical trial within South Africa

Explanation: Section 25(4)(a) explicitly states that a patent shall not be granted for an invention the publication or exploitation of which would be expected to encourage offensive or immoral behaviour. Financial cost, state enterprise competition, and local clinical trial status are not statutory exclusions under Section 25(4).

10Regarding biological inventions, how does Section 25(4)(b) of the Patents Act 57 of 1978 limit patentability?

A.Patents cannot be granted for animal or plant varieties or essentially biological processes for their production, but microbiological processes and products are patentable

B.All biological inventions including vaccines and antibiotics are strictly non-patentable

C.Plant varieties are fully patentable under the Patents Act, while trade marks govern micro-organisms

D.Microbiological processes are excluded, but whole mammal cloning is expressly permitted

Explanation: Section 25(4)(b) provides that a patent shall not be granted for any variety of animal or plant or any essentially biological process for the production of animals or plants, 'not being a micro-biological process or the product of such a process'. Microbiological processes and products are thus patentable under SA law.

About the SAIIPL SA Patent Law & Practice Exam

Comprehensive examination prep bank covering South Africa's Patents Act 57 of 1978, CIPC filing procedures, patentability requirements, priority rights, patent maintenance, infringement, revocation, and IP rights overlap for SAIIPL trade mark practitioner candidates. MCQ-based study aid for the official assessment; it does not replace required writing, oral, portfolio, clinical, or hands-on performance.

Questions

100 scored questions

Time Limit

3 hours

Passing Score

50%

Exam Fee

R1,000–R2,500 depending on annual PEB/SAIIPL schedule (South African Institute of Intellectual Property Law (SAIIPL) & Patent Examination Board)

SAIIPL SA Patent Law & Practice Exam Content Outline

25%

Statutory Framework and Patentability Criteria

Patents Act 1978 scope, Section 25 patentability requirements, absolute novelty, inventive step, industrial application, and statutory exclusions.

25%

Filing Specifications, Priority Rights and CIPC Registration

Provisional and complete specifications, Paris Convention priority (Section 31), PCT entry, claim construction, and CIPC formal deposit system.

20%

Patent Rights, Term, Maintenance and Ownership

20-year term (Section 44), renewal fees, restoration under Section 46, Section 59 employee inventions, assignments, and compulsory licensing.

20%

Infringement, Enforcement, Defenses and Revocation

Section 45 rights, Section 65 infringement actions, statutory defenses, Section 61 revocation grounds, and Commissioner of Patents jurisdiction.

10%

IP Rights Overlap and Trade Mark Practitioner Context

Patents vs designs (Designs Act 195 of 1993) vs trade marks (Trade Marks Act 194 of 1993); functional shapes, brand protection, and IP strategy.

How to Pass the SAIIPL SA Patent Law & Practice Exam

What You Need to Know

Passing score: 50%
Exam length: 100 questions
Time limit: 3 hours
Exam fee: R1,000–R2,500 depending on annual PEB/SAIIPL schedule

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

SAIIPL SA Patent Law & Practice Study Tips from Top Performers

1Master Section 25 of Patents Act 57 of 1978 inside out, including patentability criteria, absolute novelty, inventive step, and explicit exclusions like computer programs and medical treatment methods.

2Understand the difference between South Africa's CIPC patent deposit system (formal examination only) and trade mark registration (substantive examination).

3Memorize statutory timeframes: 12 months from provisional to complete specification (extendable to 15 months), 12 months for Paris Convention priority, 31 months for PCT national phase entry, and 20 years maximum patent term.

4Study revocation grounds under Section 61, as these are the primary weapons used in South African patent litigation before the Commissioner of Patents.

5Analyze IP overlap scenarios where a product feature could qualify for patent protection, aesthetic or functional design protection under Designs Act 195 of 1993, or trade mark protection under Trade Marks Act 194 of 1993.

Frequently Asked Questions

What is the pass mark for the SAIIPL SA Patent Law and Practice examination?

The pass mark is 50% for each Group 1 statutory examination governed by the Patent Examination Board and SAIIPL.

Why must trade mark practitioners study patent law under SAIIPL rules?

SAIIPL requires trade mark practitioner candidates to understand all core IP statutes in South Africa (Group 1: Trade Mark, Patent, Copyright, and Design Law) to effectively advise clients on IP overlap, registrability, and portfolio strategy.

Does South Africa examine patent applications for substantive novelty and inventive step?

No. South Africa operates a formal deposit (registration) system for patents. CIPC examines applications for formal compliance only; validity (novelty, inventive step, patentability) is tested in litigation before the Court of the Commissioner of Patents.

What is the term of a South African patent under the Patents Act 57 of 1978?

Under Section 44 of Patents Act 57 of 1978, the term of a patent is 20 years from the date of filing of the complete specification, subject to payment of annual renewal fees starting at the end of the third year.

How are PCT international patent applications handled in South Africa?

South Africa is a PCT contracting state. Under Chapter 1A (Sections 43A–43F) of the Patents Act, an applicant has 31 months from the priority date to enter the South African national phase at CIPC.